Samsung Bioepis’ biosimilar to Humira launched in the EU
Samsung Bioepis has announced the launch of its Imraldi, an adalimumab biosimilar to Humira, in the European Union (EU); the...
Trending:
-
![employing AI to improve drug discovery]()
Verge Genomics: employing AI to improve drug discovery
-
![Roche]()
Roche reports sales growth as new drugs ease pressure from biosimilar competition
-
![AstraZeneca will continue its investment freeze in UK due to Brexit uncertainty]()
AstraZeneca to continue UK investment freeze due to Brexit uncertainty
-
![Humira]()
AbbVie and Sandoz resolve Humira biosimilar patent dispute
-
![biosimilars for Humira]()
Rival companies to tap $20bn global market with biosimilars for Humira
-
![Latin America cannabis report]()
Latin America’s medical cannabis market to reach $8.5bn by 2028
Expert commentary & analysis from GlobalData
AZ’s Brexit freeze will be short-term, but UK pharma’s future remains unclear
Europe’s updated guidelines on atopic dermatitis
How will the UK’s relaxed cannabis regulations impact clinical practice?
Trial design should give Dermira’s AD drug a better shot at Phase IIb success
Most Read
Company releases
KUBio™ – The Proven Response for Rapid Biomanufacturing
The KUBio™ modular facilities are designed to reduce project timelines while incorporating the benefits of single-use technology.
Filling and Packaging Services
Commercial Manufacturing of Non-Sterile Liquids and Semi-Solids
CPL is a leader in the manufacture of non-sterile liquid and semi-solid products. The company has earned this position by...
Analytical Testing Services for Pharmaceutical Formulation Development
Product Development, Scale-Up and Manufacture
CPL develops, scales-up and manufactures pharmaceutical products all under one roof, offering formulation services coupled...
Company whitepapers
Qualification of Powdered Gelatin Agar by NIR Spectroscopy
ABB AnalyticalFlexible Drug Containers for Parenteral Drugs
Weibel CDSDetermination of Absorption of Isopropyl Myristate in Processing Equipment and Packaging Material by Liquid Extraction and Gas Chromatography
CPLBiopharmaceuticals and Liposomal Formulations
Polymun ScientificWhy Clinical Trial Equipment Rental Could Transform Your Trial
MESMThe New HOF smartVTS Vial Transfer System
HOF SonderanlagenbauSepha Multi-Q Leak Testing System
SephaCompany A-Z
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.
Projects
Boehringer Ingelheim’s Biopharmaceutical Production Facility in Vienna, Austria
Germany-based pharmaceutical company Boehringer Ingelheim is constructing a new large-scale cell culture (LSCC) facility at its site in Vienna, Austria.
Lonza’s Ibex Biomanufacturing Complex in Visp, Switzerland
MSD’s Biologics Manufacturing Facility, Swords, Ireland
Boehringer Ingelheim’s New Tablet Production Facility, Ingelheim
BeiGene Biologics Manufacturing Facility, Guangzhou
Clinical Trials
UCLH initiates new trial for Alzheimer’s treatment in UK
The NIHR University College London Hospitals (UCLH) Clinical Research Facility in the UK has initiated a clinical trial, DESPIAD, to assess a new treatment called...
Biogen reports interim results from Spinraza’s NURTURE study
September’s top news stories
Eisai and Bial report new clinical practice data for Zebinix
Concerns over Brexit cause Recardio to cease clinical trials in the UK
Drug Development
SQZ Biotech signs up to $1bn immuno-oncology deal with Roche
Cell therapy company SQZ Biotechnologies has expanded its deal worth up to $1bn with Roche for the development and commercialisation of immune-oncology products.
Immugenyx and Janssen to develop SLE model for drug development
Allele Biotechnology gets NIH grant to develop sepsis therapies
Otsuka expands digital medicines alliance with Proteus Digital
BTG licenses ovarian cancer candidate to Carrick Therapeutics
Market Data
Roche reports sales growth as new drugs ease pressure from biosimilar competition
Swiss pharma company Roche reported 7% year on year increase in sales to CHF42.1bn ($42.5bn) in the first nine months of 2018 as newly launched...
Pain drug developer Adynxx agrees to merge with Alliqua Biomedical
Rival companies to tap $20bn global market with biosimilars for Humira
FDA panel endorses Celltrion’s biosimilar to Rituxan
Deals this week: Amicus Therapeutics, Janssen Pharmaceuticals, Ionis Pharmaceuticals
Technology
Otsuka expands digital medicines alliance with Proteus Digital
Otsuka Pharmaceutical has expanded its global collaboration agreement with Proteus Digital Health for advancing a portfolio of digital medicines and care models to help patients...
Sandoz launches second Healthcare Access Challenge
Hong Kong researchers create tiny soft robot for drug delivery
Innovate UK funds AI drug discovery platform
Pharma Technology Focus – Issue 75